Lupin 2024

The Pharmaceutical Care Management Association (PCMA) agrees that biosimilars bring more competition to the prescription drug marketplace

Webinar highlights how introduction of more biosimilars can lower Rx costs

Webinar highlights how introduction of more biosimilars can lower Rx costs

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) agrees that biosimilars bring more competition to the prescription drug marketplace, which is critical to lowering costs for patients and families. In case you missed it, IQVIA Institute held a webinar to present the findings of their recently released report, “Biosimilars in the United States: 2023-2027: Competition, Savings and Suitability.”

PP_1170x120_10-25-21